Cargando…

Mpox vaccination in global perspective: priorities and challenges

After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Jigyasa, Patel, Shailesh Kumar, Agrawal, Aditya, Channabasappa, Nikhil K., Niranjan, Ankush K., Chandra Das, Bhabesh, Pandey, Megha K., Tiwari, Sita Prasad, Gaihre, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205209/
https://www.ncbi.nlm.nih.gov/pubmed/37228971
http://dx.doi.org/10.1097/MS9.0000000000000550
_version_ 1785045986669756416
author Rana, Jigyasa
Patel, Shailesh Kumar
Agrawal, Aditya
Channabasappa, Nikhil K.
Niranjan, Ankush K.
Chandra Das, Bhabesh
Pandey, Megha K.
Tiwari, Sita Prasad
Gaihre, Milan
author_facet Rana, Jigyasa
Patel, Shailesh Kumar
Agrawal, Aditya
Channabasappa, Nikhil K.
Niranjan, Ankush K.
Chandra Das, Bhabesh
Pandey, Megha K.
Tiwari, Sita Prasad
Gaihre, Milan
author_sort Rana, Jigyasa
collection PubMed
description After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in a short span of 6 months warranting WHO to declare Mpox, a Public Health Emergency of International Concern on 23 July 2022. As the Mpox virus is crossing geographical boundaries without established transmission patterns, there is an urgent need for new scientific strategies from global researchers to contain it before turning into the next pandemic. The control of Mpox outbreaks primarily relies on various public health measures such as proper surveillance, contact tracing, rapid diagnosis, isolation and care of patients, and vaccination. At present, there are three vaccines viz. ACAM2000, MVABN, and LC16 are in consideration and have been approved in several jurisdictions for ongoing Mpox outbreak. Prioritization of individuals along with the production of specific Mpox vaccine is need of the hour to meet out the global demand of Mpox vaccination.
format Online
Article
Text
id pubmed-10205209
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102052092023-05-24 Mpox vaccination in global perspective: priorities and challenges Rana, Jigyasa Patel, Shailesh Kumar Agrawal, Aditya Channabasappa, Nikhil K. Niranjan, Ankush K. Chandra Das, Bhabesh Pandey, Megha K. Tiwari, Sita Prasad Gaihre, Milan Ann Med Surg (Lond) Correspondence, Commentaries, Perspectives After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in a short span of 6 months warranting WHO to declare Mpox, a Public Health Emergency of International Concern on 23 July 2022. As the Mpox virus is crossing geographical boundaries without established transmission patterns, there is an urgent need for new scientific strategies from global researchers to contain it before turning into the next pandemic. The control of Mpox outbreaks primarily relies on various public health measures such as proper surveillance, contact tracing, rapid diagnosis, isolation and care of patients, and vaccination. At present, there are three vaccines viz. ACAM2000, MVABN, and LC16 are in consideration and have been approved in several jurisdictions for ongoing Mpox outbreak. Prioritization of individuals along with the production of specific Mpox vaccine is need of the hour to meet out the global demand of Mpox vaccination. Lippincott Williams & Wilkins 2023-04-01 /pmc/articles/PMC10205209/ /pubmed/37228971 http://dx.doi.org/10.1097/MS9.0000000000000550 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Correspondence, Commentaries, Perspectives
Rana, Jigyasa
Patel, Shailesh Kumar
Agrawal, Aditya
Channabasappa, Nikhil K.
Niranjan, Ankush K.
Chandra Das, Bhabesh
Pandey, Megha K.
Tiwari, Sita Prasad
Gaihre, Milan
Mpox vaccination in global perspective: priorities and challenges
title Mpox vaccination in global perspective: priorities and challenges
title_full Mpox vaccination in global perspective: priorities and challenges
title_fullStr Mpox vaccination in global perspective: priorities and challenges
title_full_unstemmed Mpox vaccination in global perspective: priorities and challenges
title_short Mpox vaccination in global perspective: priorities and challenges
title_sort mpox vaccination in global perspective: priorities and challenges
topic Correspondence, Commentaries, Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205209/
https://www.ncbi.nlm.nih.gov/pubmed/37228971
http://dx.doi.org/10.1097/MS9.0000000000000550
work_keys_str_mv AT ranajigyasa mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT patelshaileshkumar mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT agrawaladitya mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT channabasappanikhilk mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT niranjanankushk mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT chandradasbhabesh mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT pandeymeghak mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT tiwarisitaprasad mpoxvaccinationinglobalperspectiveprioritiesandchallenges
AT gaihremilan mpoxvaccinationinglobalperspectiveprioritiesandchallenges